Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study)

Open access
Zühlke, Liesl, Karthikeyan, Ganesan, Engel, Mark E., Rangarajan, Sumathy, Mackie, Pam, Cupido-Katya Mauff, Blanche, Islam, Shofiqul, Daniels, Rezeen, Francis, Veronica, Ogendo, Stephen, Gitura, Bernard, Mondo, Charles, Okello, Emmy, Lwabi, Peter, Al-Kebsi, Mohammed M., Hugo-Hamman, Christopher, Sheta, Sahar S., Haileamlak, Abraham, Daniel, Wandimu, Goshu, Dejuma Yadeta, Abdissa, Senbeta G., Desta, Araya G., Shasho, Bekele A., Begna, Dufera M., ElSayed, Ahmed, Ibrahim, Ahmed S., Musuku, John, Bode-Thomas, Fidelia, Yilgwan, Christopher C., Amusa, Ganiyu A., Ige, Olukemi, Okeahialam, Basil, Sutton, Christopher, Misra, Rajeev, Abul Fadl, Azza, Kennedy, Neil, Damasceno, Albertino, Sani, Mahmoud U., Ogah, Okechukwu S., Elhassan, Taiwo OlunugaHuda H. M., Mocumbi, Ana Olga, Adeoye, Abiodun M., Mntla, Phindile, Ojji, Dike, Mucumbitsi, Joseph, Teo, Koon, Yusuf, Salim, Mayosi, Bongani M.·2016·Circulation

Abstract

Background: There are few contemporary data on the mortality and morbidity associated with rheumatic heart disease or information on their predictors. We report the 2-year follow-up of individuals with rheumatic heart disease from 14 low- and middle-income countries in Africa and Asia. Methods: Between January 2010 and November 2012, we enrolled 3343 patients from 25 centers in 14 countries and followed them for 2 years to assess mortality, congestive heart failure, stroke or transient ischemic attack, recurrent acute rheumatic fever, and infective endocarditis. Results: Vital status at 24 months was known for 2960 (88.5%) patients. Two-thirds were female. Although patients were young (median age, 28 years; interquartile range, 18–40), the 2-year case fatality rate was high (500 deaths, 16.9%). Mortality rate was 116.3/1000 patient-years in the first year and 65.4/1000 patient-years in the second year. Median age at death was 28.7 years. Independent predictors of death were severe valve disease (hazard ratio [HR], 2.36; 95% confidence interval [CI], 1.80–3.11), congestive heart failure (HR, 2.16; 95% CI, 1.70–2.72), New York Heart Association functional class III/IV (HR, 1.67; 95% CI, 1.32–2.10), atrial fibrillation (HR, 1.40; 95% CI, 1.10–1.78), and older age (HR, 1.02; 95% CI, 1.01–1.02 per year increase) at enrollment. Postprimary education (HR, 0.67; 95% CI, 0.54–0.85) and female sex (HR, 0.65; 95% CI, 0.52–0.80) were associated with lower risk of death. Two hundred and four (6.9%) patients had new congestive heart failure (incidence, 38.42/1000 patient-years), 46 (1.6%) had a stroke or transient ischemic attack (8.45/1000 patient-years), 19 (0.6%) had recurrent acute rheumatic fever (3.49/1000 patient-years), and 20 (0.7%) had infective endocarditis (3.65/1000 patient-years). Previous stroke and older age were independent predictors of stroke/transient ischemic attack or systemic embolism. Patients from low- and lower-middle–income countries had significantly higher age- and sex-adjusted mortality than patients from upper-middle–income countries. Valve surgery was significantly more common in upper-middle–income than in lower-middle– or low-income countries. Conclusions: Patients with clinical rheumatic heart disease have high mortality and morbidity despite being young; those from low- and lower-middle–income countries had a poorer prognosis associated with advanced disease and low education. Programs focused on early detection and the treatment of clinical rheumatic heart disease are required to improve outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.116.024769

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 306

Metadata

Authors
Zühlke, L., Karthikeyan, G., Engel, M. E., Rangarajan, S., Mackie, P., Cupido-Katya Mauff, B., Islam, S., Daniels, R., Francis, V., Ogendo, S., Gitura, B., Mondo, C., Okello, E., Lwabi, P., Al-Kebsi, M. M., Hugo-Hamman, C., Sheta, S. S., Haileamlak, A., Daniel, W., Goshu, D. Y., Abdissa, S. G., Desta, A. G., Shasho, B. A., Begna, D. M., ElSayed, A., Ibrahim, A. S., Musuku, J., Bode-Thomas, F., Yilgwan, C. C., Amusa, G. A., Ige, O., Okeahialam, B., Sutton, C., Misra, R., Abul Fadl, A., Kennedy, N., Damasceno, A., Sani, M. U., Ogah, O. S., Elhassan, T. O. H. M., Mocumbi, A. O., Adeoye, A. M., Mntla, P., Ojji, D., Mucumbitsi, J., Teo, K., Yusuf, S., & Mayosi, B. M.
Venue
Circulation
Published
2016-11-08
Volume
134
Issue
19
Pages
1456-1466
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2528326578
Cited by
306
References
30
FWCI
20.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). https://app.cochat.ai/papers/10.1161/circulationaha.116.024769
The paper
Zühlke, L., Karthikeyan, G., Engel, M. E., Rangarajan, S., Mackie, P., Cupido-Katya Mauff, B., Islam, S., Daniels, R., Francis, V., Ogendo, S., Gitura, B., Mondo, C., Okello, E., Lwabi, P., Al-Kebsi, M. M., Hugo-Hamman, C., Sheta, S. S., Haileamlak, A., Daniel, W., . . . Mayosi, B. M. (2016). Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. https://doi.org/10.1161/circulationaha.116.024769

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.